Status:
COMPLETED
MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI)
Lead Sponsor:
Hvidovre University Hospital
Conditions:
Hepato-Renal Syndrome
Portal Hypertension
Eligibility:
All Genders
18-78 years
Brief Summary
Heptorenal syndrome (HRS) is divided into two types. A non-acute kidney injury (NAKI-HRS), which is predominantly related to end-stage disease and a more acute kidney injury (HRS-AKI). HRS-AKI is pote...
Eligibility Criteria
Inclusion
- Patients with cirrhosis and acute hepatorenal syndrome (HRS-AKI)
- Patient of more than 18 and less than 78 years of age
Exclusion
- Patients who are unable to give informed consent
- Patients with absolute contraindication for MRI
- Patients with absolute contraindication for terlipressin
- Pregnant women
- Patient with severe hemodynamic comorbidity
Key Trial Info
Start Date :
January 8 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 21 2021
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT03483272
Start Date
January 8 2018
End Date
April 21 2021
Last Update
August 16 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hvidovre University Hospital
Hvidovre, Capital Region, Denmark, 2650
2
Centre of Gastroenterology, Dept. of medicine. Hvidovre University Hospital
Hvidovre, Denmark, 2650